Hagiwara Masatoshi, Ling Jingjing, Koenig Paul-Albert, Ploegh Hidde L
Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Mol Cell. 2016 Sep 1;63(5):753-67. doi: 10.1016/j.molcel.2016.07.014. Epub 2016 Aug 25.
ER-associated degradation (ERAD) is essential for protein quality control in the ER, not only when the ER is stressed, but also at steady state. We report a new layer of homeostatic control, in which ERAD activity itself is regulated posttranscriptionally and independently of the unfolded protein response by adjusting the endogenous levels of EDEM1, OS-9, and SEL1L (ERAD enhancers). Functional UBC6e requires its precise location in the ER to form a supramolecular complex with Derlin2. This complex targets ERAD enhancers for degradation, a function that depends on UBC6e's enzymatic activity. Ablation of UBC6e causes upregulation of active ERAD enhancers and so increases clearance not only of terminally misfolded substrates, but also of wild-type glycoproteins that fold comparatively slowly in vitro and in vivo. The levels of proteins that comprise the ERAD machinery are thus carefully tuned and adjusted to prevailing needs.
内质网相关降解(ERAD)对于内质网中的蛋白质质量控制至关重要,不仅在内质网应激时如此,在稳态时也是如此。我们报道了一种新的稳态控制层面,其中ERAD活性本身通过调节EDEM1、OS-9和SEL1L(ERAD增强子)的内源性水平在转录后受到调控,且独立于未折叠蛋白反应。功能性UBC6e需要其在内质网中的精确位置才能与Derlin2形成超分子复合物。该复合物靶向ERAD增强子进行降解,这一功能依赖于UBC6e的酶活性。UBC6e的缺失会导致活性ERAD增强子上调,从而不仅增加了对终末错误折叠底物的清除,还增加了在体外和体内折叠相对缓慢的野生型糖蛋白的清除。因此,构成ERAD机制的蛋白质水平会根据当前需求进行仔细调整。